 CAMBRIDGE, Mass.--BUSINESS WIRE--Axcella Nasdaq: AXLA, a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator EMM compositions, today announced that management will participate in the following upcoming investor conferences: SVB Leerink 10th Annual Global Healthcare Conference: The companys fireside chat will be webcast on February 26, 2021 at 9:20 a.m. ET. H.C. Wainwright Global Life Sciences Con 